On the other hand, although statistical significance was not reached, the use of GLP-1RAs showed a trend towards a reduced risk of nine respiratory diseases (pneumonia, pulmonary fibrosis, dyspnea, acute respiratory failure, pleural effusion, COPD, sleep apnea syndrome, and pulmonary embolism)
doi: 10.1016/j.mam.2021.101026 34
By targeting additional pathways beyond GLP-1, retatrutide may provide more comprehensive appetite suppression and metabolic effects
The sugar-free version of Liquid IV contains sodium and potassium but is missing calcium, magnesium, and chloride entirely
doi:10.1542/peds.103.3.e26
GLP-1 Liquid Drops boost metabolism, curb cravings & maintain balanced blood sugar